Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Covalon Technologies Ltd CVALF


Primary Symbol: V.COV

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold... see more

Recent & Breaking News (TSXV:COV)

Infection Prevention Solutions Provider Covalon to Participate for the First Time in NEO - The Conference for Neonatology in Las Vegas, NV on February 22-24, 2023

PR Newswire February 20, 2023

Covalon Announces Conference Call to Discuss First Quarter Fiscal 2023 Financial Results

PR Newswire February 17, 2023

Covalon Announces Fourth Quarter and Year End Results for Fiscal 2022 and Highlights Company Transformation Changes

PR Newswire January 25, 2023

Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2022 Financial Results

PR Newswire January 23, 2023

Covalon's SurgiClear Dressing Plays an Important Part in Preventing Surgical Wound Infections at Top Children's Hospital

Canada NewsWire November 21, 2022

Covalon Launches New "CLABSI Conscious" Campaign to Help Children Heal Without Infections

PR Newswire November 8, 2022

Closing Chronic Wounds with Collagen Powder: University of Michigan case study demonstrates the efficacy of ColActive Plus Powder in resolving non-healing wounds

PR Newswire November 1, 2022

Covalon to Participate in the American Nurses Credentialing Center Magnet Conference in Philadelphia

Canada NewsWire October 11, 2022

Covalon to Participate in the 12th International Pediatric Intestinal Failure and Rehabilitation Symposium in Toronto

PR Newswire September 28, 2022

Covalon to Showcase Infection Prevention Solutions at the Association for Vascular Access Annual Scientific Meeting

PR Newswire September 26, 2022

Covalon's Dual Antimicrobial Surgical Site Dressing Adopted by Leading US Pediatric Hospital's Congenital Heart Program

PR Newswire September 20, 2022

Covalon to Introduce New Infection Prevention Products at the Annual Association of Pediatric Hematology/Oncology Nurses (APHON) Conference

PR Newswire September 13, 2022

Covalon Announces Expansion of its United States Pediatric Hospital Customer Base

PR Newswire September 8, 2022

Covalon Announces Issuance of Stock Options

PR Newswire September 7, 2022

Covalon Announces Third Quarter Fiscal 2022 Results

PR Newswire August 29, 2022

Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2022 Financial Results

PR Newswire August 24, 2022

Covalon Enters into Automatic Share Purchase Plan

PR Newswire June 30, 2022

Covalon Announces Second Quarter Fiscal 2022 Results

PR Newswire May 30, 2022

Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2022 Financial Results

PR Newswire May 26, 2022

COVALON TECHNOLOGIES LTD. ANNOUNCES NORMAL COURSE ISSUER BID

Canada NewsWire May 25, 2022